DK0650733T3 - Levende svækket in ovo-vaccine - Google Patents

Levende svækket in ovo-vaccine

Info

Publication number
DK0650733T3
DK0650733T3 DK94117270T DK94117270T DK0650733T3 DK 0650733 T3 DK0650733 T3 DK 0650733T3 DK 94117270 T DK94117270 T DK 94117270T DK 94117270 T DK94117270 T DK 94117270T DK 0650733 T3 DK0650733 T3 DK 0650733T3
Authority
DK
Denmark
Prior art keywords
live
microorganism
ovo
modified
modified microorganism
Prior art date
Application number
DK94117270T
Other languages
English (en)
Inventor
Peter John Coloe
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0650733T3 publication Critical patent/DK0650733T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94117270T 1993-11-03 1994-11-02 Levende svækket in ovo-vaccine DK0650733T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14720793A 1993-11-03 1993-11-03
CN94117813A CN1106299A (zh) 1993-11-03 1994-11-04 卵内活疫苗

Publications (1)

Publication Number Publication Date
DK0650733T3 true DK0650733T3 (da) 2002-03-11

Family

ID=36940636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94117270T DK0650733T3 (da) 1993-11-03 1994-11-02 Levende svækket in ovo-vaccine

Country Status (13)

Country Link
US (1) US6231871B1 (da)
EP (1) EP0650733B1 (da)
JP (1) JPH07206705A (da)
CN (1) CN1106299A (da)
AT (1) ATE211922T1 (da)
AU (1) AU7763294A (da)
CA (1) CA2134835C (da)
DE (1) DE69429646T2 (da)
DK (1) DK0650733T3 (da)
ES (1) ES2169061T3 (da)
NZ (1) NZ264845A (da)
PT (1) PT650733E (da)
ZA (1) ZA948643B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2155129T3 (es) * 1995-06-07 2001-05-01 Pfizer Vacunacion in ovo contra la coccidiosis.
SK282436B6 (sk) 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
JP2000502257A (ja) * 1995-12-19 2000-02-29 アイオワ ステート ユニバーシティー リサーチ ファウンデーション，インコーポレーテッド ヘテロフィル適合化家禽用ワクチン
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6410222B1 (en) 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
WO2001053508A2 (en) * 2000-01-20 2001-07-26 Omegatech, Inc. Methods for raising rabbits
DE60136563D1 (de) * 2000-11-16 2008-12-24 Intervet Int Bv Salmonella vakzine
CA2452841C (en) 2001-08-30 2012-10-02 Embrex, Inc. Method of sporulating eimeria oocytes
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
US7357935B2 (en) 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis
WO2005024005A1 (en) * 2003-09-03 2005-03-17 Intralytix, Inc. Novel salmonella bacteriophage and uses thereof
WO2005053737A1 (en) 2003-12-03 2005-06-16 Pfizer Products Inc. In ovo vaccination of campylobacter in avian species
CN1276076C (zh) * 2004-12-14 2006-09-20 华东理工大学 一种鳗弧菌野生毒株的无标记基因缺失减毒突变株及其应用
US20060196428A1 (en) * 2005-03-03 2006-09-07 Correa Rafael S Method for improving chick hatchability
RU2409385C2 (ru) * 2006-03-30 2011-01-20 Эмбрекс, Инк. Способ иммунизации птицы против инфекции, вызванной бактериями clostridium
UA100370C2 (uk) 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
JP5554231B2 (ja) * 2007-06-13 2014-07-23 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション トリの生産形質の改変
AR072976A1 (es) * 2008-08-08 2010-10-06 Wyeth Corp Virus de bronquitis infecciosa (ib) aislado, composicion de vacuna y metodo para preparar un virus de bronquitis infecciosa (ib) atenuado vivo
MX364733B (es) 2012-10-26 2019-05-06 Intervet Int Bv Vacunas de salmonella de protección cruzada.
WO2023170057A1 (en) 2022-03-08 2023-09-14 Hipra Scientific, S.L.U. In ovo vaccine compositions against coccidiosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851006A (en) 1955-11-03 1958-09-09 Swift & Co Hatching of eggs
US3120834A (en) 1961-11-01 1964-02-11 Vineland Poultry Lab Method of introducing adjusvants into avian egg interiors
US3256856A (en) 1964-08-19 1966-06-21 Francis C Moore Method of introducing small controlled amounts of treatment materials into avian eggs
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
JPS61500663A (ja) * 1983-12-13 1986-04-10 コモンウエルス　サイエンテイフイツク　アンド　インダストリアル　リサ−チ　オ−ガナイゼイシヨン 感染性嚢病ウィルスワクチン
IL85980A (en) * 1987-04-16 1992-03-29 Embrex Inc Disease control in avian species by embryonal vaccination with a nonreplicating immunogen
US5206015A (en) 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
DE69030383T2 (de) * 1989-10-02 1997-10-23 Univ Arkansas Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6048535A (en) * 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine

Also Published As

Publication number Publication date
CA2134835C (en) 2008-06-03
CN1106299A (zh) 1995-08-09
NZ264845A (en) 1997-09-22
JPH07206705A (ja) 1995-08-08
EP0650733B1 (en) 2002-01-16
ATE211922T1 (de) 2002-02-15
US6231871B1 (en) 2001-05-15
DE69429646D1 (de) 2002-02-21
ES2169061T3 (es) 2002-07-01
CA2134835A1 (en) 1995-05-04
DE69429646T2 (de) 2002-11-14
AU7763294A (en) 1995-05-18
ZA948643B (en) 1995-07-07
PT650733E (pt) 2002-06-28
EP0650733A1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DK0650733T3 (da) Levende svækket in ovo-vaccine
WO2000004919A3 (en) Live attenuated salmonella vaccines to control avian pathogens
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
SE9003198L (sv) Fiskvaccin omfattande en virulent, invasiv bakterie
Heddleston et al. Fowl cholera: immune response in turkeys
HUT65367A (en) Method for the preparation of chicken anaemia agent vaccine
Muhammad et al. Effect of physico-chemical factors on survival of avian influenza virus (H7N3 type)
Barnes et al. Susceptibility of turkey poults from vaccinated and unvaccinated hens to alcaligenes rhinotracheitis (turkey coryza)
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
Gross Escherichia coli as a complicating factor of Newcastle disease vaccination
Richey et al. The effect of congenital passive immunity levels on the response of chicks to Newcastle disease vaccination
Montgomery et al. Observations on the pathogenicity of Alcaligenes faecalis in chickens
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
HU0100908D0 (en) Chicken anaemia viruses of low pathogenicity
JPH07121874B2 (ja) 感染性気管支炎ワクチン
Odagiri et al. Immunity of chicks against colibacillosis by vaccination of parent breeders
DE69208854D1 (de) Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
HUT37353A (en) Process for producing vaccine for treating infective laryngitis and trachitis of fowls
Saif-Edin IMMUNIZATION OF DUCKS AGAINST PASTEURELLA MULTOCIDA INFECTION BY AVIRULENT CU STRAIN 1-EFFICACY AND SAFETY OF THE VACCINE
TH62279A (th) วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส